Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients
- 31 July 1991
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 40 (1), 121-128
- https://doi.org/10.1038/ki.1991.189
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Analysis of immune status of hemodialyzed adults: Association with prior transfusionsKidney International, 1984
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- Active hepatitis B vaccination of dialysis patients and medical staffKidney International, 1984
- The Role of Monocytes and Responder Cells in Suppression of Antigen-Specific T Cell Proliferation in Chronic Renal FailureInternational Archives of Allergy and Immunology, 1984
- Suppressor cells assayed by numerical and functional tests in chronic renal failureKidney International, 1982
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTSThe Lancet, 1981
- Tuberculosis in patients undergoing maintenance hemodialysisAmerican Journal Of Medicine, 1979
- The effect of uremia and transplantation on lymphocyte subpopulationsKidney International, 1976
- IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATIONThe Journal of Experimental Medicine, 1964
- PROLONGED SURVIVAL OF SKIN HOMOGRAFTS IN UREMIC PATIENTSAnnals of the New York Academy of Sciences, 1957